None listed
Conditions
Interventions
Dietary Supplement : Start administration of the test food within 12 hours of surgery and discharge after a certain period of time (Visit 3, Week 1: From the start of administration to the discharge o
Sponsors
The Catholic University of Korea, Uijeongbu St. Mary’s Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? Adult men and women aged 20 to 80 years old ? Patients with colorectal cancer diagnosed histologically and imagingly, and who are scheduled for right colon resection ? Before the clinical trial begins, consent to participation in this clinical trial and sign a written consent.
Exclusion criteria
Exclusion criteria: ? Those suffering from metastatic colon cancer ? Those who received chemotherapy or radiation therapy before surgery ? Patients with a history of severe cerebrovascular disease (cerebral infarction, cerebral hemorrhage, etc.), severe heart disease (unsafe angina, myocardial infarction, arrhythmia requiring heart failure treatment) ? Those with neurological or psychologically important medical history or currently suffering from a disease ? Those with a history of alcoholism or substance abuse ? People with immune system, infectious, gastrointestinal diseases (inflammatory bowel disease) ? Uncontrolled thyroid disease ? Creatinine is more than twice the normal upper limit of the test ? Those whose AST(GOT) and ALT(GPT) are more than 3 times the normal range ? Patients with uncontrolled hypertension (160/100mmHg or more, measured after 10 minutes of rest for the subject) ? Patients with uncontrolled diabetes (fasting blood sugar greater than 180mg/dl) ? Those who have taken or used probiotics or antibiotics within the last 1 week ? Pregnant women, lactating women, women of childbearing age who have a pregnancy plan or who do not agree with the selection of appropriate contraceptive methods ? Patients who have not performed the planned operation (right colon resection) ? Those who are judged to be inappropriate for this clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of bowel movements using the number of bowel movements per day and Bristol stool chart | — |
Secondary
| Measure | Time frame |
|---|---|
| Cancer patient quality of life questionnaire (EORTC QLQ-C30) | — |
Countries
Korea, Republic of
Contacts
Public ContactJAEIM LEE
The Catholic University of Korea, Uijeongbu St. Mary’s Hospital
Outcome results
None listed